AMAG Pharma (AMAG) Posts Q3 Loss of $1.88/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Oracle shares drop on AI spending concerns and Microsoft criticism
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
AMAG Pharmaceuticals (AMAG) PT Lowered to $20 at Piper Jaffray
November 1, 2018 1:20 PM EDTPiper Jaffray analyst Christopher Raymond lowered the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $20.00 (from $22.00) while maintaining a Neutral rating.
Raymond said the 2019 guidance was a 'bit of a bombshell'.
... MoreAMAG Pharmaceuticals (AMAG) PT Lowered to $19 at Cowen
November 1, 2018 12:43 PM EDTCowen analyst Ken Cacciatore lowered the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $19.00 (from $25.00) while maintaining a Market Perform rating following results.
Cacciatore notes the company is taking an aggressive and understandable approach of investing in their current new product cycle.
... More


